These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36265539)
21. CD93 a potential player in cytotrophoblast and endothelial cell migration. Fantone S; Tossetta G; Di Simone N; Tersigni C; Scambia G; Marcheggiani F; Giannubilo SR; Marzioni D Cell Tissue Res; 2022 Jan; 387(1):123-130. PubMed ID: 34674045 [TBL] [Abstract][Full Text] [Related]
22. Soluble expression of disulfide-bonded C-type lectin like domain of human CD93 in the cytoplasm of Escherichia coli. Nativel B; Figuester A; Andries J; Planesse C; Couprie J; Gasque P; Viranaicken W; Iwema T J Immunol Methods; 2016 Dec; 439():67-73. PubMed ID: 27742562 [TBL] [Abstract][Full Text] [Related]
23. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2). Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791 [TBL] [Abstract][Full Text] [Related]
24. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy. Sun Y; Chen W; Torphy RJ; Yao S; Zhu G; Lin R; Lugano R; Miller EN; Fujiwara Y; Bian L; Zheng L; Anand S; Gao F; Zhang W; Ferrara SE; Goodspeed AE; Dimberg A; Wang XJ; Edil BH; Barnett CC; Schulick RD; Chen L; Zhu Y Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321321 [TBL] [Abstract][Full Text] [Related]
25. Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets. Guo A; Zhang J; Tian Y; Peng Y; Luo P; Zhang J; Liu Z; Wu W; Zhang H; Cheng Q Front Immunol; 2022; 13():907182. PubMed ID: 36389798 [TBL] [Abstract][Full Text] [Related]
26. Multimerin-2 orchestrates the cross-talk between endothelial cells and pericytes: A mechanism to maintain vascular stability. Fejza A; Poletto E; Carobolante G; Camicia L; Andreuzzi E; Capuano A; Pivetta E; Pellicani R; Colladel R; Marastoni S; Doliana R; Iozzo RV; Spessotto P; Mongiat M Matrix Biol Plus; 2021 Aug; 11():100068. PubMed ID: 34435184 [TBL] [Abstract][Full Text] [Related]
27. Soluble CD93 is an apoptotic cell opsonin recognized by α Blackburn JWD; Lau DHC; Liu EY; Ellins J; Vrieze AM; Pawlak EN; Dikeakos JD; Heit B Eur J Immunol; 2019 Apr; 49(4):600-610. PubMed ID: 30656676 [TBL] [Abstract][Full Text] [Related]
28. Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma. Bao L; Tang M; Zhang Q; You B; Shan Y; Shi S; Li L; Hu S; You Y Biochem Biophys Res Commun; 2016 Aug; 476(4):467-474. PubMed ID: 27255994 [TBL] [Abstract][Full Text] [Related]
30. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q. McGreal EP; Ikewaki N; Akatsu H; Morgan BP; Gasque P J Immunol; 2002 May; 168(10):5222-32. PubMed ID: 11994479 [TBL] [Abstract][Full Text] [Related]
31. CD93 and related family members: their role in innate immunity. Greenlee MC; Sullivan SA; Bohlson SS Curr Drug Targets; 2008 Feb; 9(2):130-8. PubMed ID: 18288964 [TBL] [Abstract][Full Text] [Related]
32. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910 [TBL] [Abstract][Full Text] [Related]
33. Modulated interaction of the ERM protein, moesin, with CD93. Zhang M; Bohlson SS; Dy M; Tenner AJ Immunology; 2005 May; 115(1):63-73. PubMed ID: 15819698 [TBL] [Abstract][Full Text] [Related]
34. The crystal structure of the platelet activator aggretin reveals a novel (alphabeta)2 dimeric structure. Hooley E; Papagrigoriou E; Navdaev A; Pandey AV; Clemetson JM; Clemetson KJ; Emsley J Biochemistry; 2008 Jul; 47(30):7831-7. PubMed ID: 18597489 [TBL] [Abstract][Full Text] [Related]
35. Regulation of CD93 cell surface expression by protein kinase C isoenzymes. Ikewaki N; Kulski JK; Inoko H Microbiol Immunol; 2006; 50(2):93-103. PubMed ID: 16490927 [TBL] [Abstract][Full Text] [Related]
36. Role of CD93 in Health and Disease. Tossetta G; Piani F; Borghi C; Marzioni D Cells; 2023 Jul; 12(13):. PubMed ID: 37443812 [TBL] [Abstract][Full Text] [Related]
37. Structural insight into CD93 recognition by IGFBP7. Xu Y; Sun Y; Zhu Y; Song G bioRxiv; 2023 Jun; ():. PubMed ID: 37333140 [TBL] [Abstract][Full Text] [Related]
38. CD93 has a crucial role in pathogenesis of psoriasis. Shehata WA; Maraee AH; Tayel N; Mohamed AS; Abd El Gayed EM; Elsayed NBAE; Mostafa MI; Bazid HAS J Cosmet Dermatol; 2022 Apr; 21(4):1616-1624. PubMed ID: 34028163 [TBL] [Abstract][Full Text] [Related]
39. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Boyington JC; Riaz AN; Patamawenu A; Coligan JE; Brooks AG; Sun PD Immunity; 1999 Jan; 10(1):75-82. PubMed ID: 10023772 [TBL] [Abstract][Full Text] [Related]
40. CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche. Chevrier S; Genton C; Kallies A; Karnowski A; Otten LA; Malissen B; Malissen M; Botto M; Corcoran LM; Nutt SL; Acha-Orbea H Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3895-900. PubMed ID: 19228948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]